First Published by HANNAH ADLER for Cannabiz JULY 23, 2021 Pharmacologists at the University of Sydney have found clues which could help solve the riddle of the entourage effect — why low-dose CBD products containing a full-spectrum of cannabinoids seem to have therapeutic impacts at relatively low [...]
Curaleaf is bringing its second range of medical cannabis flower products to the UK market to improve access for patients. Medical marijuana concept with dry cannabis buds and stethoscope on white reflective surface Europe’s largest vertically integrated cannabis company Curaleaf, formally known as EMMAC Life Science Group, [...]
The first such study in the world aims to find out if Sativex combined with chemotherapy can help treat glioblastoma Sativex is already given to patients with multiple sclerosis. Photograph: Sativex First Published by Denis Campbell for The Guardian Tue 3 Aug 2021 Cancer charities and the NHS [...]
Increasing Use of Medical Marijuana to Alleviate Symptoms, Treat Diseases and Conditions and in Pain Management are Key Factor Driving Industry Growth, says Emergen Research Emergen Research Logo Click Here to Access Free sample PDF Copy of the Report https://www.emergenresearch.com/request-sample/174 The global medical cannabis market size is expected to [...]
Emily and Spencer say Clover relies on the cannabis oil they have been buying from The Netherlands The parents of an epileptic two-year-old are paying £1k a month for medical cannabis they cannot get on the NHS. Emily Howis and Spencer Carret said the treatment has [...]
Ben Langley is founder and chief executive of the medical cannabis provider Grow Group Ben Langley, founder and CEO of the Grow Group, a biopharmaceutical company focused solely on cannabis based medicines and improving global access to those medicines (Image c. Martin Townsend) First Published By Sarah [...]
Eligible patients in the UK can apply for the UK’s new medical cannabis card – Cancard. The Cancard is a validated indication to the police, or any third party, that you are consuming cannabis for medical reasons, aiming to protect those using self-sourced illegal cannabis for medicinal purposes [...]
In a study with 35 women, who did moderate-intensity aerobic exercise, the blood levels of the endocannabinoid anandamide increased and fear decreased. The study was conducted by investigators of several institutions in the USA. Participant completed a 3-day fear acquisition (day 1), extinction (day 2), and [...]
In a long-term open extension trial of CBD in patients with Lennox-Gastautsyndrome (LGS ) the plant cannabinoid was effective in reducing seizure frequency for up to 156 weeks. Patients received plant-derived highly purified CBD (Epidiolex in the United States; Epidyolex in the EURopean Union; 100 mg/ml oral [...]
According to a case report presented by investigators of the Medical University of Warsaw, Poland, and the Medical School of Hannover, Germany, the use of cannabis may be helpful in the treatment of stuttering. They presented the case of a 20-year-old male with treatment-resistant stuttering, who [...]
Copyright © 2024 | The Cannabis Pages | All Rights Reserved | Important Notice | The Cannabis Pages “TCP” is an information resource for medical cannabis patients and prescribers. Nothing on the site should be construed as a promotion or inducement. TCP does not promote any product or represent that the products mentioned on TCP’s website are treatment for any kind of medical condition. TCP cannot guarantee that information provided is error-free or complete and is not responsible for the quality of the information provided by users. Cannabis is an unlicensed medication which can only be administered under the supervision of a licensed physician.
